IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lion Point Capital, LP

Q3 2025 Holdings

Filed 2025-11-14 | 27 holdings | $17.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Mineralys Therapeutics Inc(MLYS)COM603170101$1.5M39,0008.4%
Milestone Pharmaceuticals in(MIST)COM59935V107$1.3M658,5537.5%
Fennec Pharmaceuticals Inc(FENC)COM31447P100$1.2M123,0006.5%
Jasper Therapeutics Inc(JSPR)COM NEW471871202$948.6K398,5585.4%
Avadel Pharmaceuticals PLCCOM SHSG29687103$911.6K59,7005.2%
Kiniksa Pharmaceuticals Intl(KNSA)ORD SHS CL AG52694109$908.6K23,4005.2%
Insmed Inc(INSM)COM PAR $.01457669307$900.1K6,2505.1%
Ardelyx Inc(ARDX)COM039697107$896.8K162,7505.1%
Benitec Biopharma Inc(BNTC)COM NEW08205P209$869.9K62,0004.9%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$846.2K55,0004.8%
Royalty Pharma PLC(RPRX)SHS CLASS AG7709Q104$755.0K21,4004.3%
Disc Medicine Inc(IRON)COM254604101$700.4K10,6004.0%
Bridgebio Pharma Inc(BBIO)COM10806X102$690.8K13,3003.9%
Geron Corp(GERN)COM374163103$685.0K500,0003.9%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$665.4K35,3003.8%
Regenxbio Inc(RGNX)COM75901B107$557.3K57,7503.2%
Seres Therapeutics Inc(MCRB)COM NEW81750R201$522.1K27,1383.0%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$484.0K67,5002.7%
Kura Oncology Inc(KURA)COM50127T109$407.1K46,0002.3%
Biohaven LTD(BHVN)COMG1110E107$340.7K22,7001.9%
Compass Pathways PLC(CMPS)SPONSORED ADS20451W101$332.3K58,0001.9%
Praxis Precision Medicines I(PRAX)COM NEW74006W207$302.1K5,7001.7%
DAY One Biopharmaceuticals I(DAWN)COM23954D109$296.1K42,0001.7%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$280.4K86,0001.6%
Mersana Therapeutics Inc(MRSN)COM59045L205$199.9K25,7601.1%
Humacyte Inc(HUMA)COM44486Q103$145.3K83,5000.8%
Spruce Biosciences Inc(SPRB)COM NEW85209E208$9.0K1,0000.1%